Related Experiment Video
Updated: Aug 14, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
[Acute interstitial pneumopathy with fever caused by hydroxyurea]
P L Blanc1, J M Joasson, H Hammoud
1Service de Médecine D, Centre Hospitalier, Annonay.
Background:
Hydroxyurea has few side effects excepting the known bone marrow toxicity. Fever with or without pneumonia has occasionally been reported.
Case Report:
A patient given hydroxyurea for polycythemia suddenly developed severe interstitial pneumonia with fever and hypoxemia. All bacteriological tests were negative and an empirical antibiotic regimen was ineffective. Fever recurred after reintroducing hydroxyurea and definitive cure was achieved after its withdrawal. The clinical course was rapidly favorable without the need for corticosteroids.
Discussion:
Fever, and in some cases interstitial pneumonia, in patients given hydroxyurea generally suggests an infection. However, 15 cases of pneumonia have been reported as caused by hydroxyurea in patients treated for a myeloproliferative syndrome. Delay to onset is 3 to 8 weeks after initiating treatment. The course is favorable after withdrawal, with or without corticosteroids. Fever may be the only sign of a drug reaction, resolving with withdrawal and recurring at re-challenge. The underlying mechanism remains unknown. Definitive cure can be achieved by discontinuing hydroxyurea, avoiding the need for further investigations.
Related Concept Videos
Increased Body Temperature
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Acute Pyelonephritis I: Introduction
Atypical Pneumonia
Pneumonia I: Introduction